Pacific Premier Bancorp, Inc. (PPBI) Reaches $38.40 After 6.00% Down Move; Shorts at GW Pharmaceuticals Plc Ads (GWPH) Raised By 2.87%

December 8, 2017 - By Louis Casey

The stock of Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) is a huge mover today! The stock decreased 1.54% or $0.6 during the last trading session, reaching $38.4. About 139,874 shares traded. Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) has risen 45.98% since December 8, 2016 and is uptrending. It has outperformed by 29.28% the S&P500.The move comes after 8 months negative chart setup for the $1.78 billion company. It was reported on Dec, 8 by Barchart.com. We have $36.10 PT which if reached, will make NASDAQ:PPBI worth $106.50 million less.

GW Pharmaceuticals Plc Ads (NASDAQ:GWPH) had an increase of 2.87% in short interest. GWPH’s SI was 3.45 million shares in December as released by FINRA. Its up 2.87% from 3.36 million shares previously. With 251,000 avg volume, 14 days are for GW Pharmaceuticals Plc Ads (NASDAQ:GWPH)’s short sellers to cover GWPH’s short positions. The SI to GW Pharmaceuticals Plc Ads’s float is 15.94%. The stock decreased 0.08% or $0.1 during the last trading session, reaching $124.87. About 163,321 shares traded. GW Pharmaceuticals plc (NASDAQ:GWPH) has risen 31.90% since December 8, 2016 and is uptrending. It has outperformed by 15.20% the S&P500.

Among 13 analysts covering GW Pharmaceuticals (NASDAQ:GWPH), 11 have Buy rating, 1 Sell and 1 Hold. Therefore 85% are positive. GW Pharmaceuticals had 22 analyst reports since August 13, 2015 according to SRatingsIntel. Roth Capital maintained GW Pharmaceuticals plc (NASDAQ:GWPH) rating on Monday, March 14. Roth Capital has “Buy” rating and $160 target. Leerink Swann maintained GW Pharmaceuticals plc (NASDAQ:GWPH) on Monday, October 2 with “Outperform” rating. Cantor Fitzgerald maintained it with “Buy” rating and $208.0 target in Friday, September 29 report. On Friday, June 3 the stock rating was initiated by Cantor Fitzgerald with “Buy”. The firm has “Buy” rating by TH Capital given on Monday, November 30. Janney Capital initiated the stock with “Sell” rating in Monday, June 27 report. The company was maintained on Tuesday, August 8 by Cantor Fitzgerald. The company was maintained on Monday, December 5 by Cantor Fitzgerald. The stock has “Buy” rating by Roth Capital on Monday, November 30. Maxim Group maintained the stock with “Buy” rating in Thursday, June 8 report.

GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company has market cap of $3.17 billion. It operates through three divisions: Commercial, Sativex Research and Development, and Pipeline Research and Development. It currently has negative earnings. The firm markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis.

Since June 15, 2017, it had 0 insider buys, and 1 insider sale for $226,875 activity. LAGOMARSINO SIMONE sold $226,875 worth of Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) on Thursday, June 15.

Analysts await Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) to report earnings on January, 23. They expect $0.41 earnings per share, down 8.89% or $0.04 from last year’s $0.45 per share. PPBI’s profit will be $18.95M for 23.41 P/E if the $0.41 EPS becomes a reality. After $0.50 actual earnings per share reported by Pacific Premier Bancorp, Inc. for the previous quarter, Wall Street now forecasts -18.00% negative EPS growth.

Among 7 analysts covering Pacific Premier Bancorp (NASDAQ:PPBI), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Pacific Premier Bancorp had 13 analyst reports since September 28, 2015 according to SRatingsIntel. On Monday, June 26 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. The stock has “Outperform” rating by Wood on Friday, October 2. Piper Jaffray initiated Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) on Monday, September 28 with “Overweight” rating. FBR Capital maintained the stock with “Outperform” rating in Thursday, July 21 report. The stock of Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) has “Buy” rating given on Friday, August 18 by Piper Jaffray. Piper Jaffray maintained the shares of PPBI in report on Thursday, October 5 with “Buy” rating. The firm has “Outperform” rating by FBR Capital given on Friday, July 1. As per Thursday, April 21, the company rating was maintained by DA Davidson. The firm earned “Buy” rating on Tuesday, July 25 by Stephens. The company was downgraded on Tuesday, October 11 by FBR Capital.

Investors sentiment increased to 2.12 in 2017 Q2. Its up 0.92, from 1.2 in 2017Q1. It is positive, as 16 investors sold Pacific Premier Bancorp, Inc. shares while 26 reduced holdings. 23 funds opened positions while 66 raised stakes. 32.55 million shares or 32.35% more from 24.59 million shares in 2017Q1 were reported. Ack Asset Mgmt Limited Liability Co has invested 1.04% of its portfolio in Pacific Premier Bancorp, Inc. (NASDAQ:PPBI). Moreover, State Street Corporation has 0% invested in Pacific Premier Bancorp, Inc. (NASDAQ:PPBI). Price T Rowe Associates Md holds 0.02% of its portfolio in Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) for 2.38M shares. Hbk L P holds 0.01% or 20,200 shares in its portfolio. Wells Fargo & Mn stated it has 84,761 shares. Northern Corporation owns 563,179 shares for 0.01% of their portfolio. Invesco Limited holds 105,247 shares. Moreover, Quantbot Techs L P has 0% invested in Pacific Premier Bancorp, Inc. (NASDAQ:PPBI) for 1,141 shares. Wellington Mgmt Group Llp invested in 2.29 million shares. Envestnet Asset Management stated it has 3,004 shares. Panagora Asset Management reported 4,147 shares. Tiaa Cref Investment Limited Liability Com invested in 233,320 shares. Driehaus Capital Mngmt Lc owns 152,936 shares or 0.21% of their US portfolio. Next Century Growth Investors Ltd Liability, Minnesota-based fund reported 26,726 shares. Captrust Fin Advsrs owns 261 shares for 0% of their portfolio.

Pacific Premier Bancorp, Inc. operates as the bank holding firm for Pacific Premier Bank that provides banking services to businesses, professionals, real estate investors, and non-profit organizations. The company has market cap of $1.78 billion. The Company’s deposit products include checking, money market, and savings accounts. It has a 23.66 P/E ratio. The companyÂ’s loan portfolio comprises commercial business loans, lines of credit, U.S. small business administration loans, warehouse credit facilities, commercial real estate loans, residential home loans, construction loans, and consumer loans, as well as banking products for homeowners associations and franchise lending.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: